BioRestorative Therapies Inc (BRTX)

[trader59]

The O/S is 5.8M and unrestricted is 5.5M. That ain't Auctus. The O/S is the shares "issued and outstanding." Auctus isn't supposed to be issued stock that would make them a beneficial owner.

The units of a share of stock and a warrant for $10 is done, the "guarantee" is expired.

Performance is the foundation of NASDAQ valuations. It's OK to anticipate and invest in potential improvement, sometimes to an extreme. This ain't Tesla.

What NASDAQ sees is a company that went bankrupt on the OTC, tossed its toxic lenders a handsome profit during the proceedings, and the stock essentially went illiquid on the OTC locking in its prime toxic lender with an unpaid loan and dirt cheap warrants there was no market to sell into, they made them a deal so they could exit with additional profit. NASDAQ also sees a "clinical trial" biotech company that had their trial approved nearly 5 years ago and haven't started it. NASDAQ sees a big risk.